ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

ANGPTL4 Negatively Regulate the Progression of Osteosarcoma by Remodeling Branched-Chain Amino Acid Metabolism

ANGPTL4は分岐鎖アミノ酸代謝のリモデリングを介して骨肉腫の進行を負に制御する (機械翻訳の邦題)

Lin S, Miao Y, Zheng X, et al.
研究デザイン種別未確定
対象未確定

記録の確認項目

研究デザイン
種別未確定
対象
未確定
出版年
記録なし
出典
doi.org
抄録の表示
表示あり
出版状態
未確認
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
確認待ち
記録状態
公開

出版状態の注記

出版状態: 未確認

Europe PMC lookup failed; publication status remains unknown.

状態の根拠を見る →

日本語要約(機械生成)

骨肉腫(OS)におけるANGPTL4の機能を検討した。臨床検体と細胞株でANGPTL4発現が低下しており、ノックダウンにより細胞増殖とコロニー形成が亢進した。RNA-seq解析により、ANGPTL4低下がBCAA/mTORシグナルを活性化し、BCAA蓄積がmTOR経路を介して細胞増殖を促進することが示された。さらに、ゼノグラフトマウスモデルでも同経路が確認され、ANGPTL4はBCAA/mTOR軸を介してOS進行を負に制御することが示唆された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Background: : Angiopoietin-like-4 (ANGPTL4), a secreted glycoprotein that is mainly recognized as a regulator in lipid metabolism, now, is implied in the regulation of the growth and metastasis of various carcinomas. However, less is known about its functions in the progression of sarcomas, let alone osteosarcoma (OS), which is the most common malignant diagnosed in musculoskeletal system. Methods: : The expression of ANGPTL4 in clinical OS samples and cell lines paired with their controls were analyzed in both mRNA and protein levels. Cell functional analysis including proliferation and colony formation were carried out to detect the roles ANGPTL4 takes in the progress of OS using stable ANGPTL4 overexpression and knockdown HOS/MNNG cell lines. The RNA-Seq and bioinformatics analysis were then employed to discover the BCAA metabolism related signaling which is involved in ANGPTL4 functioning on HOS/MNNG cell growth. Furthermore, BCAAs content measurement, and BCATs rescue experiments were performed to confirm the BCAA/mTOR signaling axis that ANGPTL4 triggered in HOS/MNNG cells. Finally, a xenograft mouse model was carried out to further verify the ANGPTL4 /BCAA/mTOR signaling axis discovered. Results: : We found that the expression of ANGPTL4 is reduced in clinical OS tissues and cell lines compared to cancellous bone tissues and BMSCs, respectively. The knockdown of ANGPTL4 in HOS/MNNG cells results in enhanced cell growth and clone formation. Moreover, BCAA/mTOR signaling axis were discovered to be triggered by ANGPTL4 down regulation in HOS/MNNG cell using RNA-seq. It was also verified that the accumulation of BCAAs activates the mTOR signaling pathway, and in turn promotes HOS/MNNG cell growth using BCAAs content measurement, and BCAT inhibition. Finally, the IHC results of xenograft mouse model also confirmed this ANGPTL4/BCAA/mTOR signaling axis in vivo . Conclusions: : Taken together, our results demonstrate that the expression of ANGPTL4 were negatively related to OS progress. Moreover, it was found the down-regulation of ANGPTL4 promoted OS cell growth via BCAAs/mTOR axis.

DOI 10.21203/rs.3.rs-1209880/v1

原文・出典を見る →